Cargando…

Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis

Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubois-Camacho, Karen, Diaz-Jimenez, David, De la Fuente, Marjorie, Quera, Rodrigo, Simian, Daniela, Martínez, Maripaz, Landskron, Glauben, Olivares-Morales, Mauricio, Cidlowski, John A., Xu, Xiaojiang, Gao, Guangping, Xie, Jun, Chnaiderman, Jonás, Soto-Rifo, Ricardo, González, María-Julieta, Calixto, Andrea, Hermoso, Marcela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879552/
https://www.ncbi.nlm.nih.gov/pubmed/31824476
http://dx.doi.org/10.3389/fimmu.2019.02449
_version_ 1783473623726555136
author Dubois-Camacho, Karen
Diaz-Jimenez, David
De la Fuente, Marjorie
Quera, Rodrigo
Simian, Daniela
Martínez, Maripaz
Landskron, Glauben
Olivares-Morales, Mauricio
Cidlowski, John A.
Xu, Xiaojiang
Gao, Guangping
Xie, Jun
Chnaiderman, Jonás
Soto-Rifo, Ricardo
González, María-Julieta
Calixto, Andrea
Hermoso, Marcela A.
author_facet Dubois-Camacho, Karen
Diaz-Jimenez, David
De la Fuente, Marjorie
Quera, Rodrigo
Simian, Daniela
Martínez, Maripaz
Landskron, Glauben
Olivares-Morales, Mauricio
Cidlowski, John A.
Xu, Xiaojiang
Gao, Guangping
Xie, Jun
Chnaiderman, Jonás
Soto-Rifo, Ricardo
González, María-Julieta
Calixto, Andrea
Hermoso, Marcela A.
author_sort Dubois-Camacho, Karen
collection PubMed
description Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patients. MicroRNAs present a distorted feature in inflamed colonic mucosa and are potential IL-33 regulating candidates in UC. Therefore, we studied the microRNA and mRNA profiles in inflamed colonic samples of UC patients, evaluating the effect of a microRNA (selected by in silico analysis and its expression in UC patients), on IL-33 under inflammatory conditions. We found that inflamed mucosa (n = 8) showed increased expression of 40 microRNAs and 2,120 mRNAs, while 49 microRNAs and 1,734 mRNAs were decreased, as determined by microarrays. In particular, IL-33 mRNA showed a 3.8-fold increase and eight members of a microRNA family (miR-378), which targets IL-33 mRNA in the 3′UTR, were decreased (−3.9 to −3.0 times). We selected three members of the miR-378 family (miR-378a-3p, miR-422a, and miR-378c) according to background information and interaction energy analysis, for further correlation analyses with IL-33 expression through qPCR and ELISA, respectively. We determined that aUC (n = 24) showed high IL-33 levels, and decreased expression of miR-378a-3p and miR-422a compared to inactive UC (n = 10) and controls (n = 6). Moreover, both microRNAs were inversely correlated with IL-33 expression, while miR-378c does not show a significant difference. To evaluate the effect of TNFα on the studied microRNAs, aUC patients with anti-TNF therapy were compared to aUC receiving other treatments. The levels of miR-378a-3p and miR-378c were higher in aUC patients with anti-TNF. Based on these findings, we selected miR-378a-3p to exploring the molecular mechanism involved by in vitro assays, showing that over-expression of miR-378a-3p decreased the levels of an IL-33 target sequence β-gal-reporter gene in HEK293 cells. Stable miR-378a-3p over-expression/inhibition inversely modulated IL-33 content and altered viability of HT-29 cells. Additionally, in an inflammatory context, TNFα decreased miR-378a-3p levels in HT-29 cells enhancing IL-33 expression. Together, our results propose a regulatory mechanism of IL-33 expression exerted by miR-378a-3p in an inflammatory environment, contributing to the understanding of UC pathogenesis.
format Online
Article
Text
id pubmed-6879552
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-68795522019-12-10 Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis Dubois-Camacho, Karen Diaz-Jimenez, David De la Fuente, Marjorie Quera, Rodrigo Simian, Daniela Martínez, Maripaz Landskron, Glauben Olivares-Morales, Mauricio Cidlowski, John A. Xu, Xiaojiang Gao, Guangping Xie, Jun Chnaiderman, Jonás Soto-Rifo, Ricardo González, María-Julieta Calixto, Andrea Hermoso, Marcela A. Front Immunol Immunology Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized by mucosa damage associated with an uncontrolled inflammatory response. This immunological impairment leads to altered inflammatory mediators such as IL-33, which is shown to increase in the mucosa of active UC (aUC) patients. MicroRNAs present a distorted feature in inflamed colonic mucosa and are potential IL-33 regulating candidates in UC. Therefore, we studied the microRNA and mRNA profiles in inflamed colonic samples of UC patients, evaluating the effect of a microRNA (selected by in silico analysis and its expression in UC patients), on IL-33 under inflammatory conditions. We found that inflamed mucosa (n = 8) showed increased expression of 40 microRNAs and 2,120 mRNAs, while 49 microRNAs and 1,734 mRNAs were decreased, as determined by microarrays. In particular, IL-33 mRNA showed a 3.8-fold increase and eight members of a microRNA family (miR-378), which targets IL-33 mRNA in the 3′UTR, were decreased (−3.9 to −3.0 times). We selected three members of the miR-378 family (miR-378a-3p, miR-422a, and miR-378c) according to background information and interaction energy analysis, for further correlation analyses with IL-33 expression through qPCR and ELISA, respectively. We determined that aUC (n = 24) showed high IL-33 levels, and decreased expression of miR-378a-3p and miR-422a compared to inactive UC (n = 10) and controls (n = 6). Moreover, both microRNAs were inversely correlated with IL-33 expression, while miR-378c does not show a significant difference. To evaluate the effect of TNFα on the studied microRNAs, aUC patients with anti-TNF therapy were compared to aUC receiving other treatments. The levels of miR-378a-3p and miR-378c were higher in aUC patients with anti-TNF. Based on these findings, we selected miR-378a-3p to exploring the molecular mechanism involved by in vitro assays, showing that over-expression of miR-378a-3p decreased the levels of an IL-33 target sequence β-gal-reporter gene in HEK293 cells. Stable miR-378a-3p over-expression/inhibition inversely modulated IL-33 content and altered viability of HT-29 cells. Additionally, in an inflammatory context, TNFα decreased miR-378a-3p levels in HT-29 cells enhancing IL-33 expression. Together, our results propose a regulatory mechanism of IL-33 expression exerted by miR-378a-3p in an inflammatory environment, contributing to the understanding of UC pathogenesis. Frontiers Media S.A. 2019-11-20 /pmc/articles/PMC6879552/ /pubmed/31824476 http://dx.doi.org/10.3389/fimmu.2019.02449 Text en Copyright © 2019 Dubois-Camacho, Diaz-Jimenez, De la Fuente, Quera, Simian, Martínez, Landskron, Olivares-Morales, Cidlowski, Xu, Gao, Xie, Chnaiderman, Soto-Rifo, González, Calixto and Hermoso. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Dubois-Camacho, Karen
Diaz-Jimenez, David
De la Fuente, Marjorie
Quera, Rodrigo
Simian, Daniela
Martínez, Maripaz
Landskron, Glauben
Olivares-Morales, Mauricio
Cidlowski, John A.
Xu, Xiaojiang
Gao, Guangping
Xie, Jun
Chnaiderman, Jonás
Soto-Rifo, Ricardo
González, María-Julieta
Calixto, Andrea
Hermoso, Marcela A.
Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
title Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
title_full Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
title_fullStr Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
title_full_unstemmed Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
title_short Inhibition of miR-378a-3p by Inflammation Enhances IL-33 Levels: A Novel Mechanism of Alarmin Modulation in Ulcerative Colitis
title_sort inhibition of mir-378a-3p by inflammation enhances il-33 levels: a novel mechanism of alarmin modulation in ulcerative colitis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6879552/
https://www.ncbi.nlm.nih.gov/pubmed/31824476
http://dx.doi.org/10.3389/fimmu.2019.02449
work_keys_str_mv AT duboiscamachokaren inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT diazjimenezdavid inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT delafuentemarjorie inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT querarodrigo inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT simiandaniela inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT martinezmaripaz inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT landskronglauben inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT olivaresmoralesmauricio inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT cidlowskijohna inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT xuxiaojiang inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT gaoguangping inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT xiejun inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT chnaidermanjonas inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT sotoriforicardo inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT gonzalezmariajulieta inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT calixtoandrea inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis
AT hermosomarcelaa inhibitionofmir378a3pbyinflammationenhancesil33levelsanovelmechanismofalarminmodulationinulcerativecolitis